iHuman
10 hedge funds and large institutions have $532K invested in iHuman in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
167% more capital invested
Capital invested by funds: $199K → $532K (+$333K)
67% more funds holding
Funds holding: 6 → 10 (+4)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.11% more ownership
Funds ownership: 0.1% → 0.21% (+0.11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$93.9K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$93.2K |
| 3 |
HF
HRT Financial
New York
|
+$36.7K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$30.1K |
| 5 |
VF
Virtu Financial
New York
|
+$24.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$20.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.41K |
IH Hedge Fund Activity: Q1 2025 in Review
10 of the 7,463 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q1 2025, worth a combined $532K — up 167% from $199K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new IH positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $93.9K. The largest seller was RhumbLine Advisers, cutting an estimated $20.9K.
- 10 institutional investors held iHuman (IH) as of Q1 2025, up from 6 in Q4 2024.
- Funds reported $532K of iHuman stock for Q1 2025, up 167% quarter-over-quarter.
- 4 funds opened new iHuman positions in Q1 2025 and 0 closed out, a net change of +4 holders.
- The largest iHuman buyer in Q1 2025 was Morgan Stanley, an estimated $93.9K added.
- The largest iHuman seller in Q1 2025 was RhumbLine Advisers, an estimated $20.9K sold.
Based on aggregated 13F filings for Q1 2025.